Investor
INVESTOR
Disclosures information
| Date | Disclosure title | Observer |
|---|---|---|
| 2026/06/22 | Contract for Sales or Supply | |
| 2026/05/27 | Material Management Information related to Judgment of Investment(질병관리청 국립보건연구원 중증열성혈소판감소증후군(SFTS) 치료용 항체 비임상 시료 생산체계 고도화 및 평가과제 협상대상자 선정 ) | |
| 2026/05/06 | Additional Listing(국내사모 CB전환) | KOSDAQ STOCK MKT. |
| 2026/03/31 | Outcomes of Annual Meeting of Shareholders | |
| 2026/03/11 | Resolutions for Convocation of General Meeting of Shareholders | |
| 2026/03/05 | Submission of Audit Report | |
| 2026/02/03 | 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | |
| 2025/09/26 | Outcomes of Extraordinary General Meeting of Shareholders | |
| 2025/08/20 | Resolutions for Convocation of General Meeting of Shareholders(임시주주총회) | |
| 2025/05/28 | Additional Listing(유상증자(제3자배정)) | KOSDAQ STOCK MKT. |